These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5887756)

  • 41. [Principles of speciation of the plague causative agent Yersinia pestis: gradualism or saltation?].
    Suntsov VV; Suntsova NI
    Izv Akad Nauk Ser Biol; 2009; (6):645-53. PubMed ID: 20146413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pathways of exogenous adenine transformation into nucleic acid guanine in the plague bacillus].
    Maĭskiĭ VG; Suchkov IuG
    Vopr Med Khim; 1970; 16(1):72-7. PubMed ID: 5435391
    [No Abstract]   [Full Text] [Related]  

  • 43. [Establishment and evaluation of identification method for Yersinia pestis and Yersinia pseudotuberculosis].
    Shi G; Zhang Z; Mei L; Chen J; Mei S; Jin D; Zhang Z; Wang Y; Zhang X; Luo Y; Sun J; Yu D; Xia L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):496-500. PubMed ID: 26080641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
    Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
    Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yersinia ironomics: comparison of iron transporters among Yersinia pestis biotypes and its nearest neighbor, Yersinia pseudotuberculosis.
    Forman S; Paulley JT; Fetherston JD; Cheng YQ; Perry RD
    Biometals; 2010 Apr; 23(2):275-94. PubMed ID: 20049509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioluminescent tracing of a Yersinia pestis pCD1
    Zhou Y; Zhou J; Ji Y; Li L; Tan Y; Tian G; Yang R; Wang X
    Microbes Infect; 2018 Mar; 20(3):166-175. PubMed ID: 29180033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How the structural gene products of Yersinia pestis relate to virulence.
    Brubaker RR
    Future Microbiol; 2007 Aug; 2(4):377-85. PubMed ID: 17683274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physiological basis for rhamnose utilization by a mutant of Pasteurella pestis. I. Experiments with resting cells; the isolation of lactic aldehyde.
    ENGLESBERG E
    J Bacteriol; 1957 Jul; 74(1):8-11. PubMed ID: 13462953
    [No Abstract]   [Full Text] [Related]  

  • 49. Oxidative metabolism of Pasteurella pestis grown in vitro and in vivo.
    FUKUI GM; DELWICHE EA; MORTLOCK RP; SURGALLIA MJ
    J Infect Dis; 1962; 110():143-6. PubMed ID: 13895820
    [No Abstract]   [Full Text] [Related]  

  • 50. [The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].
    Drobkov VI; Marakulin IV; Pogorel'skiĭ IP; Darmov IV; Smirnov EV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):81-5. PubMed ID: 8701667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotype differences and lack of biofilm formation characterize Yersinia pseudotuberculosis infection of the Xenopsylla cheopis flea vector of Yersinia pestis.
    Erickson DL; Jarrett CO; Wren BW; Hinnebusch BJ
    J Bacteriol; 2006 Feb; 188(3):1113-9. PubMed ID: 16428415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physiological basis for rhamnose utilization by a mutant of Pasteurella pestis. II. A single mutational event leading to the production of two enzymes.
    ENGLESBERG E
    Arch Biochem Biophys; 1957 Sep; 71(1):179-93. PubMed ID: 13459440
    [No Abstract]   [Full Text] [Related]  

  • 53. [Nucleoproteins of a virulent strain of plague microbe].
    KANCHUKH AA; ZAPLATINA SI; BASOVA NN
    Ukr Biokhim Zh; 1962; 34():176-86. PubMed ID: 14453542
    [No Abstract]   [Full Text] [Related]  

  • 54. [Quantitative study of the utilization of sugars by Pasteurella pestis strain E. V. in nonproliferating suspensions. II. Glucose. Autodestruction, at 37 degrees, of the power to degrade glucose by bacteria cultivated at 26 degrees].
    DODIN A; BRYGOO ER
    Ann Inst Pasteur (Paris); 1960 May; 98():676-81. PubMed ID: 13817155
    [No Abstract]   [Full Text] [Related]  

  • 55. [Glycerin utilization by Pasteurella pestis].
    Golubinskiĭ EP; Tynianova VI; Domaradskiĭ IV
    Vopr Med Khim; 1972; 18(2):194-7. PubMed ID: 4679582
    [No Abstract]   [Full Text] [Related]  

  • 56. Biological and biochemical behavior of Pasteurella pestis and Pasteurella pseudotuberculosis.
    DEVIGNAT R
    Bull World Health Organ; 1954; 10(3):463-94. PubMed ID: 13160765
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ecological interactions among Yersinia in their common reservoir, the rodent].
    Alonso JM
    Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):414-7. PubMed ID: 11000952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b.
    Skurnik M; Peippo A; Ervelä E
    Mol Microbiol; 2000 Jul; 37(2):316-30. PubMed ID: 10931327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of Yersinia pestis EV76 6 MD plasmid on the composition of outer membrane proteins of Yersinia pseudotuberculosis YPIII].
    Zarenko MI; Goncharov EK
    Mol Gen Mikrobiol Virusol; 1991 Mar; (3):16-9. PubMed ID: 1857369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.